Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2014-02-03Clinical Trial Update: Prevalence of Dissociative Disorders in Children [NA]
A completed pediatric clinical trial studying the prevalence of dissociative disorders and schizophrenia, sponsored by Centre Hospitalier Un…
-
CLINICAL_TRIALS research · 2014-01-31Clinical Trial Update: Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
This open-label pilot study assessed the pharmacokinetics of aripiprazole in adults with Bipolar I Disorder or schizophrenia; the study is c…
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: Electroconvulsive Therapy (ECT) in Patients With Super Refractory Schizophrenia [Phase 4]
This clinical trials update reports on a Phase 4 study evaluating electroconvulsive therapy for patients with refractory schizophrenia and s…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: EMR Data to Assess Monitoring of Patients Treated With Quetiapine
AstraZeneca conducted an EMR-based analysis to assess how patients treated with quetiapine are monitored in real-world clinical practice; th…
-
CLINICAL_TRIALS research · 2014-01-28Clinical Trial Update: Physician Survey on Monitoring of Patients Treated With Quetiapine
A completed physician survey update concerning monitoring practices for patients treated with quetiapine (Seroquel).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot [Phase 1]
A Phase 1 multiple-dose study evaluated safety, tolerability, and pharmacokinetics of aripiprazole long-acting injectable depot in adults wi…
-
CLINICAL_TRIALS research · 2014-01-20Clinical Trial Update: Tandospirone Combined With Atypical Antipsychotic Drugs in Schizophrenia [Phase 4]
This document reports a Phase 4 clinical trial update on tandospirone in combination with atypical antipsychotic drugs for schizophrenia; cu…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Symptomatic Remission and Social Function in Participants Treated With Paliperidone Extended Release (ER) [Phase 4]
A Phase 4 clinical trial update evaluating paliperidone extended-release for achieving symptomatic remission and improving social functionin…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole [Phase 3]
An open-label Phase 3 trial comparing hospitalization rates in schizophrenia patients treated with oral antipsychotics versus intramuscular …
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: A Study to Evaluate Flexible Dose of Paliperidone Extended Release (ER) and Clinical Response in Participants With Schizophrenia [Phase 4]
This Phase 4 clinical trial update reports the results of a flexible-dose paliperidone extended-release regimen in adults with schizophrenia…
-
CLINICAL_TRIALS trial_result · 2014-01-13Clinical Trial Update: Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and Quetiapine
This completed clinical trial evaluated body mass index and metabolic changes after switching from olanzapine, risperidone, or quetiapine to…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials [Phase 3]
Aripiprazole for schizophrenia outpatients has completed Phase 3 trials, with results posted in 2014 as part of a Bristol-Myers Squibb and O…
-
CLINICAL_TRIALS research · 2014-01-09Clinical Trial Update: Investigator Initiated Study - Asenapine Early Psychosis [Phase 4]
Investigator-initiated Phase 4 study evaluating asenapine for early psychosis; status is not provided.
-
CLINICAL_TRIALS research · 2014-01-07Clinical Trial Update: Duration of Untreated Psychosis (DUP) and Pathways to Care in Nordland
A completed clinical trial from the University Hospital of North Norway examining duration of untreated psychosis and pathways to care in sc…
-
CLINICAL_TRIALS trial_result · 2014-01-06Clinical Trial Update: Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia. [Phase 3]
An open-label Phase 3 study evaluated flexible-dose paliperidone extended-release for treating adolescent schizophrenia; results were posted…
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Network Dysfunction, Schizophrenia and Pharmacological Magnetic Resonance Imaging (phMRI) [NA]
A completed clinical trial update from the Medical University of Vienna investigating network dysfunction related to schizophrenia using pha…
-
CLINICAL_TRIALS trial_result · 2013-12-31Clinical Trial Update: Treatment With Ziprasidone for Schizophrenia Patients With Obsessive Compulsive Disorder (OCD) [NA]
A completed clinical trial evaluating ziprasidone as a treatment for patients with schizophrenia who also have obsessive-compulsive disorder…
-
CLINICAL_TRIALS withdrawal · 2013-12-23Clinical Trial Update: Zyprexa and Task Engagement in Schizophrenia [Phase 3]
A Phase 3 trial evaluating Zyprexa (olanzapine) for task engagement in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia [Phase 3]
A Phase 3 trial evaluating long-acting injectable risperidone for schizophrenia and schizoaffective disorder has completed. Results were pos…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Will Decreased Noradrenergic Activity Normalize Information Processing in Patients With Schizophrenia? [NA]
A completed clinical trial evaluating whether decreased noradrenergic activity can normalize information processing in patients with schizop…
-
FDA approval · 2013-12-19FDA Approved: HALOPERIDOL DECANOATE — Supplemental Application (Patriot Pharmaceuticals LLC)
The FDA approved a supplemental application for HALOPERIDOL DECANOATE from Patriot Pharmaceuticals LLC.
-
FDA approval · 2013-12-17FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone) from Viatris Specialty LLC, indicating a regulatory action to modify or upd…
-
CLINICAL_TRIALS trial_result · 2013-12-17Clinical Trial Update: Adjunctive Aripiprazole in the Treatment of Risperidone-Induced Hyperprolactinemia [NA]
A clinical trial update evaluating adjunctive aripiprazole for risperidone-induced hyperprolactinemia in schizophrenia.
-
CLINICAL_TRIALS withdrawal · 2013-12-16Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) as Therapeutical Strategy for Negative Symptoms in Schizophrenia [Phase 2]
Phase 2 trial evaluating transcranial direct current stimulation for negative symptoms in schizophrenia has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-12-13Clinical Trial Update: Predictors of Treatment Outcome for Smokers With and Without Schizophrenia
This clinical trial update reports predictors of treatment outcomes for smokers with and without schizophrenia, with results posted.